KRON
Kronos Bio (KRON)
$96
About Kronos Bio (KRON)
Kronos Bio, Inc. is a clinical development biopharmaceutical company. It engages in the business of developing therapeutics that target dysregulated transcription that causes cancer and other serious diseases. The company was founded by Arie S. Belldegrun, Joshua A. Kazam, David M. Tanen, and Christopher Wilfong on June 2, 2017 and is headquartered in San Mateo, CA.
Details
Daily high
$0.97
Daily low
$0.92
Price at open
$0.92
52 Week High
$1.60
52 Week Low
$0.69
Market cap
57.8M
Dividend yield
0.00%
Volume
78,784
Avg. volume
393,970
P/E ratio
-.66
Kronos Bio News
Details
Daily high
$0.97
Daily low
$0.92
Price at open
$0.92
52 Week High
$1.60
52 Week Low
$0.69
Market cap
57.8M
Dividend yield
0.00%
Volume
78,784
Avg. volume
393,970
P/E ratio
-.66